ALLISON LUEDKE: Open Payments
NPI 1235859299 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 9 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $46 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 4 | $80 |
| Ipsen Biopharmaceuticals, Inc | 2 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| ABBVIE INC. | 1 | $24 |
Products named: Dysport, Belbuca, RELISTOR, UBRELVY, XTAMPZA.
Industry payments across WA — which companies pay providers there.
